<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>norteavapeptides — Research Watch</title><link>https://norteavapeptides.com/news/</link><description>Selected peptide papers, methods and research context.</description><language>en</language><item><title>MOTS-c and inflammation: what a diabetic rat study measured</title><link>https://norteavapeptides.com/news/mots-c-diabetic-rat-inflammation-2026/</link><guid>https://norteavapeptides.com/news/mots-c-diabetic-rat-inflammation-2026/</guid><description>A 2026 paper examined MOTS-c in an experimental type-2-diabetes rat model. The researchers measured metabolic and inflammatory responses, including markers associated with inflammasome activity in cardiac tissue.</description><pubDate>Sun, 01 Nov 2026 12:00:00 GMT</pubDate></item><item><title>GHK-Cu: why formulation belongs in the research question</title><link>https://norteavapeptides.com/news/ghk-cu-formulation-review-2026/</link><guid>https://norteavapeptides.com/news/ghk-cu-formulation-review-2026/</guid><description>A 2026 review brings copper coordination, formulation and evidence interpretation into the same discussion. Its value for a research reader is the insistence on chemical specification: the label GHK-Cu alone does not describe every relevant property of a sample.</description><pubDate>Sun, 01 Nov 2026 12:00:00 GMT</pubDate></item><item><title>NAD+ concentration is not the same question as NAD+ flux</title><link>https://norteavapeptides.com/news/nad-metabolic-pathway-tracing/</link><guid>https://norteavapeptides.com/news/nad-metabolic-pathway-tracing/</guid><description>A 2025 methods chapter describes tracing NAD+ synthesis and consumption using labeled precursors and mass analysis. It offers a useful reading lens: a snapshot concentration and a pathway’s turnover are different measurements.</description><pubDate>Sun, 01 Nov 2026 12:00:00 GMT</pubDate></item></channel></rss>